Browsing by Author Gisev, Natasa

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 23  next >
Issue DateTitleAuthor(s)Citation
2017Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatmentBlyth, Fiona; Lintzeris, Nicholas; Pearson, Sallie-Anne; Bruno, Raimondo; Campbell, Gabrielle; Cohen, Milton L; Degenhardt, Louisa; Gisev, Natasa; Hall, Wayne; Larance, Briony; Mattick, Richard P.; Nielsen, Suzanne; Shanahan, M; Concord Clinical School: Medicine; Central Clinical School: Psychological Medicine; PharmacyDefined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment, Pharmacoepidemiology and Drug Safety, vol.26, 5, 2017,pp 587-591
2012Effect of comorbidity on the risk of death associated with antipsychotic use among community-dwelling older adultsBell, John; Chen, Timothy; Gisev, Natasa; Hartikainen, Sirpa; Korhonen, Mikko; Pharmacy; Pharmacy; PharmacyEffect of comorbidity on the risk of death associated with antipsychotic use among community-dwelling older adults, International psychogeriatrics, vol.24, 7, 2012,pp 1058-1064
2009An expert panel assessment of comprehensive medication reviews for clients of community mental health teams.Bell, John; Chen, Timothy; Gisev, Natasa; O'Reilly, Claire; Rosen, Alan; Pharmacy; Pharmacy; Pharmacy; Pharmacy; School of Medical Sciences: Brain & Mind Research InstituteAn expert panel assessment of comprehensive medication reviews for clients of community mental health teams., Social Psychiatry and Psychiatric Epidemiology, vol.N/A, 10.1007/s00127-009-0148-8,pp N/A-N/A
2014Factors associated with antipsychotic polypharmacy and high-dose antipsychotics among individuals receiving compulsory treatment in the communityChen, Timothy; Gisev, Natasa; Bell, J Simon; Pharmacy; PharmacyFactors associated with antipsychotic polypharmacy and high-dose antipsychotics among individuals receiving compulsory treatment in the community, Journal of Clinical Psychopharmacology, vol.34, 3, 2014,pp 307-312
2016Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiatedBlanch, Bianca; Degenhardt, Louisa; Dobbins, Timothy A.; Gisev, Natasa; Larance, Briony; Larney, Sarah; Pearson, Sallie-Anne; School of Medical Sciences: PharmacologyInitiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated, British Journal of Clinical Pharmacology, vol.82, N/A, 2016,pp 1123-1133
2016Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiatedBlanch, Bianca; Degenhardt, Louisa; Dobbins, Timothy A.; Gisev, Natasa; Larance, Briony; Larney, Sarah; Pearson, Sallie-Anne; School of Medical Sciences: PharmacologyInitiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated, British Journal of Clinical Pharmacology, vol.82, N/A, 2016,pp 1123-1133
2011Mortality associated with benzodiazepines and benzodiazepine-related drugs among community-dwelling older people in Finland: a population-based retrospective cohort studyBell, John; Chen, Timothy; Gisev, Natasa; Hartikainen, Sirpa; Korhonen, Mikko; Pharmacy; Pharmacy; PharmacyMortality associated with benzodiazepines and benzodiazepine-related drugs among community-dwelling older people in Finland: a population-based retrospective cohort study, The Canadian Journal of Psychiatry (online), vol.56, 6, 2011,pp 377-381
2014Opioid substitution therapy as a strategy to reduce deaths in prison: Retrospective cohort studyDobbins, Timothy; Burns, Lucinda; Degenhardt, Louisa; Farrell, Michael; Gibson, Amy; Gisev, Natasa; Kimber, Jo; Larney, Sarah; School of Public Health: Public HealthOpioid substitution therapy as a strategy to reduce deaths in prison: Retrospective cohort study, BMJ Open, vol.4, 4, 2014,pp 1-8
2015The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in AustraliaBlanch, Bianca; Pearson, Sallie-Anne; Dagenhardt, Louisa; Gisev, Natasa; Larance, Briony; School of Medical Sciences: Pharmacology; PharmacyThe POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia, BMJ Open, vol.5, 1, 2015,pp e007030-N/A
2006Psychiatric Drug Use Among Patients of a Community Mental Health Service: Patterns and Implications.Bell, John Simon; Chen, Timothy; Chetty, Manoranjenni; Gisev, Natasa; McLachlan, Andrew; Pharmacy; Pharmacy; Pharmacy; Pharmacy; PharmacyPsychiatric Drug Use Among Patients of a Community Mental Health Service: Patterns and Implications., Disease Management and Health Outcomes, vol.14,(6),2006,pp 369-376
2014A retrospective study of psychotropic drug use among individuals with mental illness issued a community treatment orderChen, Timothy; Gisev, Natasa; Bell, J Simon; Pharmacy; PharmacyA retrospective study of psychotropic drug use among individuals with mental illness issued a community treatment order, International Journal of Clinical Practice, vol.68, 2, 2014,pp 236-244
2018To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?Buckley, Nicholas Allan; Blanch, Bianca; Degenhardt, Louisa; Dobbins, Timothy A.; Gisev, Natasa; Karanges, Emily A.; Larance, Briony; Larney, Sarah; Pearson, Sallie-Anne; School of Medical Sciences: PharmacologyTo what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?, Pharmacoepidemiology and Drug Safety, vol.27, 5, 2018,pp 550-555
2018To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?Buckley, Nicholas Allan; Blanch, Bianca; Degenhardt, Louisa; Dobbins, Timothy A.; Gisev, Natasa; Karanges, Emily A.; Larance, Briony; Larney, Sarah; Pearson, Sallie-Anne; School of Medical Sciences: PharmacologyTo what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?, Pharmacoepidemiology and Drug Safety, vol.27, 5, 2018,pp 550-555
2018To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?Buckley, Nicholas Allan; Blanch, Bianca; Degenhardt, Louisa; Dobbins, Timothy A.; Gisev, Natasa; Karanges, Emily A.; Larance, Briony; Larney, Sarah; Pearson, Sallie-Anne; School of Medical Sciences: PharmacologyTo what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?, Pharmacoepidemiology and Drug Safety, vol.27, 5, 2018,pp 550-555
2018To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?Buckley, Nicholas Allan; Blanch, Bianca; Degenhardt, Louisa; Dobbins, Timothy A.; Gisev, Natasa; Karanges, Emily A.; Larance, Briony; Larney, Sarah; Pearson, Sallie-Anne; School of Medical Sciences: PharmacologyTo what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?, Pharmacoepidemiology and Drug Safety, vol.27, 5, 2018,pp 550-555
2018To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?Buckley, Nicholas Allan; Blanch, Bianca; Degenhardt, Louisa; Dobbins, Timothy A.; Gisev, Natasa; Karanges, Emily A.; Larance, Briony; Larney, Sarah; Pearson, Sallie-Anne; School of Medical Sciences: PharmacologyTo what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?, Pharmacoepidemiology and Drug Safety, vol.27, 5, 2018,pp 550-555
2018To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?Buckley, Nicholas Allan; Blanch, Bianca; Degenhardt, Louisa; Dobbins, Timothy A.; Gisev, Natasa; Karanges, Emily A.; Larance, Briony; Larney, Sarah; Pearson, Sallie-Anne; School of Medical Sciences: PharmacologyTo what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?, Pharmacoepidemiology and Drug Safety, vol.27, 5, 2018,pp 550-555
2018To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?Buckley, Nicholas Allan; Blanch, Bianca; Degenhardt, Louisa; Dobbins, Timothy A.; Gisev, Natasa; Karanges, Emily A.; Larance, Briony; Larney, Sarah; Pearson, Sallie-Anne; School of Medical Sciences: PharmacologyTo what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?, Pharmacoepidemiology and Drug Safety, vol.27, 5, 2018,pp 550-555
2018To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?Buckley, Nicholas Allan; Blanch, Bianca; Degenhardt, Louisa; Dobbins, Timothy A.; Gisev, Natasa; Karanges, Emily A.; Larance, Briony; Larney, Sarah; Pearson, Sallie-Anne; School of Medical Sciences: PharmacologyTo what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?, Pharmacoepidemiology and Drug Safety, vol.27, 5, 2018,pp 550-555
2018To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?Buckley, Nicholas Allan; Blanch, Bianca; Degenhardt, Louisa; Dobbins, Timothy A.; Gisev, Natasa; Karanges, Emily A.; Larance, Briony; Larney, Sarah; Pearson, Sallie-Anne; School of Medical Sciences: PharmacologyTo what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?, Pharmacoepidemiology and Drug Safety, vol.27, 5, 2018,pp 550-555